Reference health

Bioresorbable drug-eluting magnesium-alloy scaffold: design and feasibility in a porcine coronary model

https://doi.org/10.4244/eijv8i12a218
CiteStamped reference-health badge
40/40 checkable references clean · checked 2026-07-25

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 40 checked references that resolve
resolves10.1161/CIRCULATIONAHA.110.971606
Bioresorbable Scaffold
resolves10.1093/eurheartj/ehr384
From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?
resolves10.1517/17425240802668495
Advances in stent drug delivery: the future is in bioabsorbable stents
resolves10.1136/heart.89.6.651
Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology?
resolves10.1002/ccd.20727
Safety and efficacy of bioabsorbable magnesium alloy stents in porcine coronary arteries
resolves10.1007/s00270-004-0341-9
The Road to Bioabsorbable Stents: Reaching Clinical Reality?
resolves10.1016/S0140-6736(07)60853-8
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial
resolves10.1016/j.biomaterials.2006.11.042
Coronary stents: A materials perspective
resolves10.1002/ccd.20520
First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby
resolves10.1136/hrt.2005.076562
Absorbable metal stent in human coronary arteries: imaging with intravascular ultrasound
resolves10.1093/eurheartj/ehm119
Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings
resolves10.4244/JV4I4A82
Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents
resolves10.1007/s00270-008-9472-8
AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis
resolves10.1016/j.jcin.2008.09.015
Early- and Long-Term Intravascular Ultrasound and Angiographic Findings After Bioabsorbable Magnesium Stent Implantation in Human Coronary Arteries
resolves10.1002/ccd.21091
Early restenosis following biodegradable stent implantation in an aortopulmonary collateral of a patient with pulmonary atresia and hypoplastic pulmonary arteries
resolves10.1136/hrt.2007.139261
Negative vascular remodelling after implantation of bioabsorbable magnesium alloy stents in porcine coronary arteries: a randomised comparison with bare-metal and sirolimus-eluting stents
resolves10.1016/j.jcin.2007.11.009
Evaluation of a Novel Slow-Release Paclitaxel-Eluting Stent With a Bioabsorbable Polymeric Surface Coating
resolves10.1016/j.addr.2006.01.023
The Taxus™ drug-eluting stent: A new paradigm in controlled drug delivery
resolves10.1111/j.1540-8183.2005.00084.x
Cypher Versus Taxus: Are There Differences?
resolves10.1016/S0168-3659(99)00149-2
Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(l-lactic acid) matrix
resolves10.1002/ccd.22769
Efficacy and safety of a double‐coated paclitaxel‐eluting coronary stent: The EUCATAX trial
resolves10.1016/S0735-1097(03)00119-0
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial
resolves10.7326/0003-4819-144-12-200606200-00009
Narrative Review: Drug-Eluting Stents for the Management of Restenosis: A Critical Appraisal of the Evidence
resolves10.1007/s10439-009-9719-9
Hemodynamically Driven Stent Strut Design
resolves10.1161/CIRCINTERVENTIONS.108.789974
Drug-Eluting Stents in Preclinical Studies
resolves10.1016/j.cardiores.2004.04.029
Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model
resolves10.1016/j.amjcard.2007.08.020
The Significance of Preclinical Evaluation of Sirolimus-, Paclitaxel-, and Zotarolimus-Eluting Stents
resolves10.1016/j.jacc.2007.01.069
Polymer-Based, Paclitaxel-Eluting TAXUS Liberté Stent in De Novo Lesions
resolves10.1016/0142-9612(94)90032-9
Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cells and their effects on the biocompatibility, in vivo
resolves10.1016/j.biomaterials.2005.07.037
In vitro and in vivo corrosion measurements of magnesium alloys
resolves10.1016/j.actbio.2011.05.032
A corrosion model for bioabsorbable metallic stents
resolves10.1016/j.corsci.2009.09.033
A survey of bio-corrosion rates of magnesium alloys
resolves10.3390/ijms12074250
Biodegradable Metals for Cardiovascular Stent Application: Interests and New Opportunities
resolves10.1161/CIRCULATIONAHA.109.921528
Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model
resolves10.1016/S0140-6736(09)60325-1
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
resolves10.1016/j.jacc.2008.07.006
Incidence and Correlates of Drug-Eluting Stent Thrombosis in Routine Clinical Practice
resolves10.4244/EIJV5I8A153
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry
resolves10.1016/j.jacc.2011.02.023
2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice
resolves10.1161/CIRCULATIONAHA.111.058560
Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents
The 3 references without a DOI — listed, not checked
no DOI — not checkedFirst clinical application of absorbable metal stents in the treatment of critical limb ischemia: 12-month results.
no DOI — not checkedNew coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
no DOI — not checkedSafety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-25 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.4244/eijv8i12a218"><img src="https://citestamp.com/citestamped/10.4244/eijv8i12a218/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.4244/eijv8i12a218/badge.svg)](https://citestamp.com/citestamped/10.4244/eijv8i12a218)